NO172987C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyranon-beta-d-tioxylosider - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyranon-beta-d-tioxylosider

Info

Publication number
NO172987C
NO172987C NO904088A NO904088A NO172987C NO 172987 C NO172987 C NO 172987C NO 904088 A NO904088 A NO 904088A NO 904088 A NO904088 A NO 904088A NO 172987 C NO172987 C NO 172987C
Authority
NO
Norway
Prior art keywords
group
beta
atom
thioxylosides
benzopyranon
Prior art date
Application number
NO904088A
Other languages
English (en)
Norwegian (no)
Other versions
NO904088L (no
NO172987B (no
NO904088D0 (no
Inventor
Soth Samreth
Veronique Barberousse
Patrice Renaut
Francois Bellamy
Jean Millet
Original Assignee
Fournier Ind & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8912452A external-priority patent/FR2652353B1/fr
Priority claimed from FR9003401A external-priority patent/FR2659659B1/fr
Application filed by Fournier Ind & Sante filed Critical Fournier Ind & Sante
Publication of NO904088D0 publication Critical patent/NO904088D0/no
Publication of NO904088L publication Critical patent/NO904088L/no
Publication of NO172987B publication Critical patent/NO172987B/no
Publication of NO172987C publication Critical patent/NO172987C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/12—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 3 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/14—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 6 and unsubstituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/07—Benzo[b]pyran-4-ones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06—Benzopyran radicals
    • C07H17/065—Benzo[b]pyrans
    • C07H17/075—Benzo[b]pyran-2-ones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cultivation Of Plants (AREA)
NO904088A 1989-09-22 1990-09-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyranon-beta-d-tioxylosider NO172987C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8912452A FR2652353B1 (fr) 1989-09-22 1989-09-22 Nouveaux benzopyran-2-one-beta-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.
FR9003401A FR2659659B1 (fr) 1990-03-16 1990-03-16 Nouveaux benzopyran-4-one-beta-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.

Publications (4)

Publication Number Publication Date
NO904088D0 NO904088D0 (no) 1990-09-19
NO904088L NO904088L (no) 1991-03-25
NO172987B NO172987B (no) 1993-06-28
NO172987C true NO172987C (no) 1993-10-06

Family

ID=26227568

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904088A NO172987C (no) 1989-09-22 1990-09-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyranon-beta-d-tioxylosider

Country Status (24)

Country Link
US (1) US5169838A (ko)
EP (1) EP0421829B1 (ko)
JP (1) JPH07103147B2 (ko)
KR (1) KR0142670B1 (ko)
CN (1) CN1027268C (ko)
AT (1) ATE113956T1 (ko)
AU (2) AU631456B2 (ko)
CA (1) CA2024476C (ko)
DE (1) DE69014064T2 (ko)
DK (1) DK0421829T3 (ko)
ES (1) ES2066165T3 (ko)
FI (1) FI100183B (ko)
GR (1) GR3014966T3 (ko)
HR (1) HRP920811B1 (ko)
HU (1) HU207867B (ko)
IE (1) IE65092B1 (ko)
IL (1) IL95582A (ko)
NO (1) NO172987C (ko)
NZ (1) NZ245783A (ko)
PT (1) PT95369B (ko)
RU (1) RU1838323C (ko)
SK (1) SK463890A3 (ko)
UA (1) UA13476A (ko)
YU (1) YU47867B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2801055B1 (fr) 1999-11-17 2002-02-08 Fournier Ind & Sante Derives de beta-d-5-thioxylose, procede de preparation et utilisation en therapeutique
FR2824559B1 (fr) 2001-05-11 2004-02-13 Fournier Lab Sa Nouveaux derives 5-thio-beta-xylopyronasides, procede de preparation, compositions pharmaceutiques les contenant et leur utilisation en therapeutique
FR2846966A1 (fr) * 2002-11-07 2004-05-14 Fournier Lab Sa Derive du 4-methyl-2-oxo-2h-1-benzopyran-7-yl 5-thio-beta-d- xylopyranoside, son procede de preparation et composition pharmaceutique le contenant
CA2527769A1 (en) * 2003-06-11 2004-12-16 Merck Frosst Canada Ltd. 7- (1, 3-thiazol-2-yl)thio!-coumarin derivatives and their use as leukotriene biosynthesis inhibitors
FR2860234B1 (fr) * 2003-09-25 2005-12-23 Fournier Lab Sa Nouveaux derives 666 du thioxylose
AR054226A1 (es) * 2005-02-18 2007-06-13 Smithkline Beecham Corp Composicion farmaceutica en forma de comprimido que comprende el compuesto 4-metil-2oxo-2h-1-benzopiran-7-il-tio-b-d-xilopiranosido, uso de sulfato de dermatan y de dicho compuesto para prepararla y metodo para su preparacion
FR2903698B1 (fr) * 2006-07-13 2009-01-30 Fournier S A Sa Lab Nouveaux derives de 5-thioxylopyranose.
FR2906247B1 (fr) 2006-09-27 2008-12-26 Fournier S A Sa Lab Nouveaux derives de 5-thioxylopyranose
FR2906248B1 (fr) 2006-09-27 2008-12-26 Fournier S A Sa Lab Nouveaux derives de 5-thioxylopyranose
US20090075914A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched odiparcil
CN101397315B (zh) * 2007-09-24 2013-08-07 中国医学科学院药物研究所 香豆素苷类化合物、其制法和其药物组合物与用途
FR3011468B1 (fr) 2013-10-04 2015-12-04 Inventiva Utilisation de l'odiparcil dans le traitement d'une mucopolysaccharidose
US10092540B2 (en) 2013-10-04 2018-10-09 Inventiva Method of treatment of a mucopolysaccharidosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2034306A1 (de) * 1970-07-10 1972-01-20 Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof 2 (3,4 Dimethyl-cumarin 7 yl) oxy alkylcarbonsaure Derivate und Verfahren zu ihrer Herstellung
FR2492830A1 (fr) * 1980-10-29 1982-04-30 Sori Soc Rech Ind Nouveaux composes appartenant a la famille des benzoyl- et a-hydroxybenzyl-phenyl-osides, leur procede de preparation et leur application en therapeutique
JPS6013788A (ja) * 1983-07-05 1985-01-24 Yamanouchi Pharmaceut Co Ltd 新規なクマリン誘導体
FR2549476B1 (fr) * 1983-07-20 1986-04-25 Rech Ind Benzyl-phenyl-osides, procede de preparation et utilisation en therapeutique
US4681954A (en) * 1985-10-07 1987-07-21 Pennwalt Corporation 7,8,9,10-tetrahydro-6-oxo-6H-dibenzo(b,d)pyranyloxy-propanes
FR2614893B1 (fr) * 1987-05-04 1989-12-22 Fournier Innovation Synergie Nouveaux b-d-phenyl-thioxylosides, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
CN1050544A (zh) 1991-04-10
AU631456B2 (en) 1992-11-26
KR910006283A (ko) 1991-04-29
YU178790A (sh) 1992-12-21
AU642829B2 (en) 1993-10-28
NZ245783A (en) 1993-07-27
EP0421829A1 (fr) 1991-04-10
ATE113956T1 (de) 1994-11-15
SK280827B6 (sk) 2000-08-14
DE69014064D1 (de) 1994-12-15
UA13476A (uk) 1997-04-25
DE69014064T2 (de) 1995-05-18
AU6253190A (en) 1991-03-28
PT95369A (pt) 1991-05-22
JPH03120292A (ja) 1991-05-22
DK0421829T3 (da) 1995-01-16
HU207867B (en) 1993-06-28
CA2024476A1 (en) 1991-03-23
NO904088L (no) 1991-03-25
IL95582A (en) 2001-06-14
IE65092B1 (en) 1995-10-04
CA2024476C (en) 1999-10-12
GR3014966T3 (en) 1995-05-31
NO172987B (no) 1993-06-28
US5169838A (en) 1992-12-08
ES2066165T3 (es) 1995-03-01
HRP920811B1 (en) 1998-12-31
IL95582A0 (en) 1991-06-30
FI100183B (fi) 1997-10-15
YU47867B (sh) 1996-02-19
JPH07103147B2 (ja) 1995-11-08
HU906005D0 (en) 1991-03-28
HRP920811A2 (en) 1995-10-31
FI904614A0 (fi) 1990-09-19
HUT55794A (en) 1991-06-28
RU1838323C (ru) 1993-08-30
SK463890A3 (en) 2000-08-14
EP0421829B1 (fr) 1994-11-09
AU2539792A (en) 1992-11-26
KR0142670B1 (ko) 1998-07-01
NO904088D0 (no) 1990-09-19
CN1027268C (zh) 1995-01-04
IE903414A1 (en) 1991-04-10
PT95369B (pt) 1997-06-30

Similar Documents

Publication Publication Date Title
NO172987C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyranon-beta-d-tioxylosider
ES2054020T3 (es) Compuestos biologicamente activos.
NO167035C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt beta-d-fenyltioksylosid
MX9206093A (es) Derivado de oxazolidona
IT1230595B (it) Perossiacidi immido derivati
WO1989001330A3 (en) W-arylsulphonamidoalkanoic acids for treatment of thromboxane mediated diseases
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
NO168707C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterotetracykliske laktamderivater.
IL112344A (en) Pharmaceutical compositions comprising 7, 9, 9-trisubstituted- 3-benzoyl-3, 7-diazabicyclo £3.3.1| nonanes for the treatment of cardiac arrhythmias
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
NO882340D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske oxazoloner.
ATE101115T1 (de) Salicylate, ihre salze, diese enthaltende pharmazeutische kompositionen und ihr herstellungsverfahren.
ATE95697T1 (de) Uricosuretische zusammensetzung.
ES2038702T3 (es) Un procedimiento para preparar derivados triazolopirimidina triciclicos.